Learn how first-line antiepileptic drugs, personalized care, and lifestyle changes work together to manage generalized ...

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, noted that ...

The biotech, which earlier this year laid off nearly all of its staff, also announced a PIPE that will hand it $175 million in new funding.

Such detection speed is the result of combining ML and UV absorbance spectroscopy to detect microbial contamination in cell therapy products.

For $45 million upfront, Vor Bio is gaining ex-China rights to RemeGen’s telitacicept, a first-in-class recombinant ...

The city turned over nearly 4,500 records from Chris Bausch’s personal devices in response to The Tribune’s lawsuit.

The Commission on enforced disappearance has said they found specialised interrogation rooms equipped with "torture devices" ...

This important study presents a compelling theoretical framework for understanding phase separation of membrane-bound proteins, with a focus on the organization of tight junction components. By ...

Investing.com -- Vor Biopharma Inc (NASDAQ: VOR) stock surged 85% after the company announced an exclusive licensing agreement with China’s RemeGen Co., Ltd. for telitacicept, a novel dual-target ...